# Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma

> **NCT07735819** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 61 (estimated)

## Conditions studied

- Low Grade Glioma
- Glioblastoma

## Interventions

- **DRUG:** Minocycline 200mg/day
- **DIAGNOSTIC_TEST:** [18F]FETrp PET/CT

## Key facts

- **NCT ID:** NCT07735819
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2031-06-30
- **Final completion:** 2031-06-30
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2026-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735819, "Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07735819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*